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Granuloma formation during tuberculosis
is accompanied by remodeling of host
vasculature. Walton et al. identify the
mycobacterial enzyme PcaA, which
catalyzes proximal cis-cyclopropanation
of trehalose dimycolate, as an important
determinant of granuloma-associated
angiogenesis. This form of trehalose
dimycolate induces Vegfa-mediated
angiogenesis at the granuloma,
promoting bacterial growth.
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Mycobacterial infection leads to the formation of
characteristic immune aggregates called granu-
lomas, a process accompanied by dramatic remod-
eling of the host vasculature. As granuloma angio-
genesis favors the infecting mycobacteria, it may
be actively promoted by bacterial determinants
during infection. Using Mycobacterium marinum-in-
fected zebrafish as a model, we identify the enzyme
proximal cyclopropane synthase of alpha-mycolates
(PcaA) as an important bacterial determinant of gran-
uloma-associated angiogenesis. cis-Cyclopropana-
tion of mycobacterial mycolic acids by pcaA drives
the activation of host Vegf signaling within granu-
loma macrophages. Cyclopropanation of the myco-
bacterial cell wall glycolipid trehalose dimycolate is
both required and sufficient to induce robust host
angiogenesis. Inducible genetic inhibition of angio-
genesis and Vegf signaling during granuloma forma-
tion results in bacterial growth deficits. Together,
these data reveal amechanism bywhich PcaA-medi-
ated cis-cyclopropanation of mycolic acids pro-
motes bacterial growth and dissemination in vivo
by eliciting granuloma vascularization and suggest
potential approaches for host-directed therapies.
INTRODUCTION
Upon entry into the lung, Mycobacterium tuberculosis is initially
phagocytosed by host macrophages. Pathogenic mycobacteria
evade the initial antimicrobial response through a variety of
mechanisms, and infected and uninfected macrophages form
characteristic aggregates that mature into tightly organized
structures called granulomas (Ernst, 2012; Pagan and Ramak-514 Cell Host & Microbe 24, 514–525, October 10, 2018 ª 2018 Elserishnan, 2018). The resulting environment provides a spatially
restricted focus of infection that infecting mycobacteria have
adapted to and can exploit (Pagan and Ramakrishnan, 2018; Rit-
tershaus et al., 2013).
In addition to immune cell populations, stromal cells proximal to
the granuloma undergo substantial reprogramming and remodel-
ing. Analysis of human clinical specimens and a number of animal
models revealed induction of Vegf family members by granuloma
macrophages and extensive granuloma vascularization (Datta
et al., 2015; Harding et al., 2015; Kumar et al., 2016; Oehlers
et al., 2015;Polena et al., 2016). In tumor biology there is extensive
interplay between angiogenesis and hypoxia, and, similarly,
mycobacterial granulomas in both animal models and humans
can develop hypoxic regions (Aly et al., 2007; Folkman, 2002;
Oehlers et al., 2015; Tsai et al., 2006; Ulrichs et al., 2005). Notably,
mycobacterially induced angiogenesis at the granuloma pro-
motes bacterial growth in vivo; nascent blood vessels associated
with early granulomasmay provide oxygen and nutrients, and can
create a permissive replication niche for the bacteria within (Datta
et al., 2015;Oehlers et al., 2015, 2017). Pharmacological limitation
of granuloma-associated angiogenesis or vascular normalization
results in improved host outcomes in animal models of infections
(Oehlers et al., 2015, 2017; Polena et al., 2016). As granuloma
angiogenesis favors the infecting mycobacteria, it is likely that
this host responsemaybeactively promoted, enhanced, or accel-
erated by bacterial determinants during infection.
Mycolic acids are present in the cell walls of certain Actinomy-
cetes, and have been associated with virulence for human and
animal pathogens from genera such as Mycobacterium and
Rhodococcus (Barry et al., 1998; Sydor et al., 2013). Of the my-
colic acid-containing lipids, trehalose-6,6-dimycolate (TDM) is
particularly abundant within the outer cell wall ofM. tuberculosis
(Brennan and Nikaido, 1995). TDM has been described as a
potent adjuvant and is associated with a number of aspects of
mycobacterial disease pathogenesis, including limitation of
phagolysosome fusion and activation ofmatrixmetalloproteases
(Axelrod et al., 2008; Hunter et al., 2006; Indrigo et al., 2003; Mid-
dlebrook et al., 1947; Patin et al., 2017; Sakamoto et al., 2013).vier Inc.
Studies of host recognition of TDM have implicated diverse cell
surface proteins, including Toll-like receptors, lectins, and scav-
enger receptors (Bowdish et al., 2009; Lang, 2013; Miyake et al.,
2015; Richardson and Williams, 2014). Thus, TDM may act
through multiple signaling pathways as a major modulator of
the host immune response to mycobacteria. To date, however,
relatively little attention has been paid to the angiogenic potential
of TDM, although TDM can induce angiogenesis in a rat corneal
model (Saita et al., 2000).
TDM is essential for mycobacterial viability in vivo, but a num-
ber of chemical modifications that occur within the mycolic acid
tails of TDM can be genetically targeted. The three major classes
of mycolic acids (alpha, keto, and methoxy) incorporate double
bonds or cyclopropyl groups into the proximal position of the
meromycolate chain and double bonds, cyclopropyl groups, ke-
tones, or methoxy groups into the distal position (Brennan and
Besra, 1997). These non-essential chemical modifications can
be genetically altered to study in vivo infection phenotypes
(Glickman et al., 2000, 2001).
Notably, functionalization at the proximal position with a
cyclopropyl group is associated with pathogenic species of
mycobacteria; the mycolates from M. tuberculosis, M. avium,
M. ulcerans, and M. marinum contain cylcopropyl groups at
this position, while non-pathogenic species such asM. smegma-
tis and M. chelonae possess a double bond (Daffe et al., 1991;
Liu et al., 1996). In addition, an enzyme that catalyzes the addi-
tion of cis-cyclopropyl groups to the proximal end of mycolic
acids of the alpha-mycolate class, PcaA, has been implicated
in virulence (Glickman et al., 2000). In murine models, pcaA
mutants display an in vivo growth defect at 1 week post-infec-
tion, concomitant with a reduced pro-inflammatory cytokine
response from macrophages (Glickman et al., 2000; Rao et al.,
2005). However, the influence of mycolic acid modifications on
granuloma-associated angiogenesis has not been examined.
We have previously utilized the zebrafish/M.marinummodel of
infection to study angiogenesis during mycobacterial infection
and granuloma formation (Oehlers et al., 2015). The zebrafish is
anatural host toM.marinum, a close relativeof theM. tuberculosis
complex (Tobin and Ramakrishnan, 2008). Mycobacterial patho-
genesis in zebrafishclosely resembles thatof human tuberculosis,
from macrophage aggregation and vascularization to the forma-
tion of necrotic and hypoxic granulomas (Cronan et al., 2016; Da-
vis et al., 2002; Oehlers et al., 2015; Swaim et al., 2006). UsingM.
marinum mutant strains, we demonstrate that PcaA-mediated
modifications to TDM are required to elicit a robust angiogenic
response during mycobacterial infection. We describe in vivo
growth defects for pcaA mutants that coincide with the onset of
granuloma vascularization. Furthermore, we demonstrate that
the growth advantage of wild-type bacteria over pcaA mutants
is Vegf dependent. Together, these data identify a role for TDM
in angiogenesis-driven mycobacterial expansion via Vegf induc-
tion and identify the proximal cis-cyclopropyl modification of my-
colic acid tails as crucial for TDM-mediated angiogenesis.
RESULTS
PcaA Deficiency Leads to Defects in Host Angiogenesis
To visualize vasculature within larval zebrafish, we used the
Tg(kdrl:EGFP)s843 transgenic line in which EGFP expression isdriven by the zebrafish kdrl promoter and labels all vasculature
(Jin et al., 2005). Vasculature in the larval trunk forms a stereotyp-
ical pattern around the somites (Figure 1A). After dorsal infection
withM.marinum, analysis of granulomas in the trunk provides a
ready and quantifiable measure of angiogenesis in live animals
(Figure 1B).
As we had previously found that host angiogenesis benefits in-
fecting mycobacteria, we hypothesized that specific bacterial
factors directly promote angiogenesis. The lipid-rich mycobac-
terial cell wall is a key interface between pathogen and host,
and a number of lipid species have been identified that modify
the host immune response (Brennan, 2003). The most abundant
of these is TDM, a lipid known to interact with diverse host im-
mune pathways. Deletion of the M. tuberculosis pcaA gene re-
sults in bacteria with an atypical pool of cell wall mycolic acids.
pcaA mutants lack proximal cis-cyclopropyl alpha-mycolates
and exhibit reduced proportions overall of both free alpha-myco-
lates and TDM of the alpha-mycolate class (Glickman et al.,
2000; Rao et al., 2005). Despite these alterations to the cell enve-
lope, DpcaA M. tuberculosis remain viable during infection. We
hypothesized that disruption of M. marinum pcaA gene would
confer similar cell wall alterations without compromising path-
ogen viability, providing an opportunity to probe the importance
of TDM in granuloma-associated angiogenesis.
Using a defined M. marinum transposon library, we
isolated two transposon mutants in the M. marinum pcaA
gene (C. Cosma and L. Ramakrishnan). The mutants, desig-
nated pcaATn28776 and pcaATn20324, possessed independent
transposon insertions, in opposite orientations, 10% of the
way through the open reading frame. There were no significant
differences in in vitro growth rates between wild-type M. mari-
num and the transposon mutants, with doubling times for
wild-type, pcaATn28776, and pcaATn20324 of 11.3, 11.7, and
10.9 hr, respectively, under the conditions assayed.
We constructed fluorescent versions of each transposon
strain to image both infection and angiogenesis in vivo. Both
pcaA mutants exhibited severe defects in granuloma-associ-
ated vascularization (Figure 1B). Decreased angiogenesis in
the pcaA mutants was observed from the outset of vasculariza-
tion in paired wild-type infections, at approximately 4 days
post-infection (dpi) (Figures 1B and 1C) and persisted at later
time points (Figures 1E and 1F). This phenotype could be
rescued through expression of PcaA using a constitutive pro-
moter (Figures 1B, 1D, and 1E). Granulomas formed normally
in the pcaA mutants. Differences in granuloma-associated
angiogenesis could be observed at 3 dpi, the earliest time point
at which vascularization could be observed in wild-type infec-
tions, suggesting a potentially early and direct interaction of
TDM with the host.
TDM Is Sufficient to Induce Angiogenesis
Based on the strong genetic requirement for pcaA for robust
granuloma vascularization, we asked whether TDM might
directly induce angiogenesis. To perform TDMsufficiency exper-
iments, we developed a method to administer highly hydropho-
bic TDM into the zebrafish trunk. We found that we could inject
mineral oil and surfactant (incomplete Freund’s adjuvant) at
2 days post-fertilization (dpf) to generate stable, persistent drop-
lets within the larvae. We then injected vehicle control or purifiedCell Host & Microbe 24, 514–525, October 10, 2018 515
Figure 1. Mutations in pcaA Result in Angiogenesis-Deficient Infection Foci
(A) Depiction of theM.marinum injection site within the trunk of a zebrafish larva. Bright-field and GFP channels (upper and lower panels, respectively) are shown
for clarity. Dotted line indicates approximate area shown for images in (B). Scale bar, 500 mm.
(B–E) Representative images of larvae at 4 days post-infection (dpi) infected with either wild-type, pcaATn28776, or complementedmutantM.marinum. Bacteria in
red, vasculature in green (upper panels) or white (lower panels). Blue arrows denote infection-associated angiogenesis (B). Length of abnormal vasculature at
5 dpi for infections with pcaATn20324 (C) and 4 and 5 dpi for pcaATn28776 (D and E). Representative of more than three independent experiments for each mutant.
Scale bars, 100 mm. For experiment involving pcaATn20324, ****p < 0.0001; Student’s t test. For all other statistics, *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001;
one-way ANOVA with Tukey’s multiple comparison post-test.alpha-mycolate TDM from M. bovis dissolved in vehicle into the
trunks of Tg(kdrl:EGFP) larvae at 2 dpf (Figure 2A). By 2 dpi, there
was little or no abnormal vasculature in the vehicle-injected ani-
mals (Figures 2B and 2C). In contrast, TDM-containing droplets
induced substantial abnormal vasculature, which associated
spatially with the TDM-loaded droplets (Figures 2B and 2C).
These results suggested that TDM is sufficient to evoke robust
angiogenesis and, combined with the genetic mutant data,
suggested a direct role for TDM in granuloma-associated
angiogenesis.
Given the sufficiency of alpha-mycolate TDM in inducing
angiogenesis and the requirement of mycobacterial pcaA for
in vivo infection-induced angiogenesis, we hypothesized that
PcaA-modified mycolates must be incorporated into TDM to
be pro-angiogenic in vivo. However, it has been shown previ-
ously that free mycolic acid methyl esters (MAMEs) are also
modified by PcaA, leaving open the possibility that these too
contribute to PcaA-dependent angiogenesis (Glickman et al.,
2000). Thin-layer chromatography (TLC) analysis of the TDM
used in the previous experiments contained only alpha-myco-
lates (Figure S1A). Since oxygenated mycolates (methoxy- and
keto-mycolates) have been previously identified as important
for the virulence of M. tuberculosis (Dubnau et al., 2000), we
wondered if these species would enhance or otherwise alter
the angiogenic potential we observed for pure alpha-myco-
late TDM.516 Cell Host & Microbe 24, 514–525, October 10, 2018To test these hypotheses, we compared the angiogenic ef-
fects of bulk TDM and bulk MAMEs isolated from M. tubercu-
losis, both of which possess mycolic acids modified by PcaA
as well as the primary oxygenated mycolate species. We in-
jected Tg(kdrl:EGFP) larvae with either TDM (2 mg/mL) or
MAMEs (2 mg/mL) at 2 dpf and assessed abnormal vasculariza-
tion at 4 dpf. TDM from M. tuberculosis induced robust
angiogenesis (Figures S2A and S2B), achieving levels of vascu-
larization comparable with TDM from M. bovis. The MAMEs,
however, did not induce angiogenesis above vehicle alone (Fig-
ures S2C and S2D). Together, these data support the role of
PcaA-modified TDM specifically, and not merely mycolic acids
in general, as the critical inducer of PcaA-dependent angiogen-
esis. The sufficiency of pure alpha-mycolate TDM in inducing
angiogenesis along with a lack of enhancement of this pheno-
type when oxygenated mycolates are present strongly supports
alpha-mycolate TDM as the isoform responsible for driving
vascularization.
The requirement that the cis-cyclopropyl alpha-mycolates be
incorporated into TDM in order to elicit angiogenesis suggested
that host receptors for TDM might be involved in initiating this
process. To begin to probe this mechanism, we focused on
Myd88- and FcRg-dependent signaling pathways, both of which
have been implicated in host responses to TDM (Bowdish et al.,
2009; Geisel et al., 2005; Lobato-Pascual et al., 2013;
Miyake et al., 2013; Werninghaus et al., 2009). We generated
Figure 2. Purified TDM and Mycolic Acid Glycolipids from Wild-Type Bacteria but Not pcaA Mutants Elicit Robust Angiogenesis
(A) Representative image of 2-day post-injection larvae injected dorsally with TDM. Dotted line indicates injection site and droplet coalescence. Scale
bar, 500 mm.
(B) Representative images of injections of either vehicle (left) or TDM (right) into Tg(kdrl:EGFP) animals. Blue arrows indicate abnormal vasculature (lower panels).
Scale bars, 100 mm.
(C) Quantification of abnormal vasculature induced by TDM or vehicle alone. Representative of three experiments. **p < 0.01, Student’s t test.
(D) Quantification of abnormal vasculature induced by MAGs isolated from wild-type or pcaA mutant M.marinum, with vehicle alone and TDM as negative and
positive controls, respectively. Data from three experiments combined. *p < 0.05; **p < 0.01; ****p < 0.0001; one-way ANOVA with Tukey’s multiple comparison
post-test.
(E) Frequency of presence or absence of abnormal vasculature. *p < 0.05; **p < 0.01; ***p < 0.001; Fisher’s exact test.
(F) Quantification of the length of abnormal vasculature inducedbyMAGs (5mg/mL) isolated frompcaATn28776:pcaA. MAGs fromwild-type and pcaATn28776 included
as positive and negative controls. Data from three experiments combined. *p < 0.05; ***p < 0.001; one-way ANOVA with Tukey’s multiple comparison post-test.
(G) Frequency of presence or absence of abnormal vasculature. *p < 0.05; ****p < 0.0001; Fisher’s exact test.
(H) Representative images of larvae injected with vehicle, TDM, wild-type MAGs, MAGs isolated from pcaATn28776, and MAGs isolated from pcaATn28776:pcaA.
Blue arrows indicate abnormal vasculature. Scale bars, 100 mm.CRISPR/Cas9 knockouts of Myd88 and the two zebrafish FcRg
paralogs to abrogate most Toll-like receptor and Mincle/MCL
signaling, respectively. Animals homozygous for a 22-bp dele-
tion in Exon 1 of myd88 showed no differences in TDM-induced
vascularization compared with heterozygous or wild-type
siblings (Figures S3A–S3C). For the FcRg experiments, we
generated mosaic FcRg knockout larvae in the Tg(kdrl:EGFP)
background by CRISPR/Cas9 targeting of both FcRg paralogs.
Mosaic FcRg knockout animals exhibited a significant decreasein abnormal vasculature in response to TDM compared with the
control group (Figures S3D and S3E), suggesting that FcRg con-
tributes to TDM-induced angiogenesis.
Purified Mycolic Acid-Containing Glycolipids from Wild-
Type but Not pcaAMutant Bacteria InduceAngiogenesis
We next sought to determine if the different TDM compositions
present within the cell walls of wild-type and pcaA mutant
M. marinum were responsible for differences in the in vivoCell Host & Microbe 24, 514–525, October 10, 2018 517
Figure 3. pcaA Mutants Fail to Induce Host
vegfaa Reporter Expression
(A and B) Representative images of TgBAC
(vegfaa:EGFP) larvae 5 dpi infected with either wild-
type (top), pcaA mutant (middle), or complemented
pcaA mutant M. marinum (bottom). Blue arrows
denote areas of GFP signal above normal devel-
opmental pattern (A). Scale bars, 500 mm. Quantifi-
cation of GFP signal above baseline for wild-type,
pcaA mutant, and complemented pcaA mutant
larval infections. Data from three experiments
combined. *p < 0.05; **p < 0.01; ****p < 0.0001; one-
way ANOVA with Tukey’s multiple comparison
post-test. n = 88 for wild-type infections; n = 86 for
pcaA mutant; n = 86 for complemented mutant (B).angiogenic potential between strains. We isolated free mycolic
acid-containing glycolipids (MAGs), which in mycobacteria
consist primarily of TDM (Bloch et al., 1953), from wild-type
and pcaA mutant M. marinum by overnight extraction with 2:1
chloroform:methanol followed by precipitation in acetone (Parish
and Stoker, 2001).
Resolution of the TDM species in the pcaA mutant by TLC re-
vealed a reduced proportion of alpha-mycolate-containing TDM
relative to keto- and methoxy-mycolate TDM in the pcaAmutant
relative to wild-type (Figures S1A and S1B). Similarly, the
M. tuberculosis pcaA knockout exhibits a large reduction in the
proportion of alpha-mycolate-containing TDM (Glickman et al.,
2000; Rao et al., 2005).
To confirm that M. marinum PcaA possesses the same
enzymatic function as the M. tuberculosis and M. bovis ortho-
logs, we isolated MAMEs from wild-type and pcaA mutant
M. marinum. Resolution of this fraction by TLC again revealed
a reduced proportion of alpha-mycolate MAMEs compared
with the methoxy/keto fraction (Figures S1C and S1D).
Importantly, 1H nuclear magnetic resonance on the alpha-
mycolate fractions showed a 12-fold reduction in cis-cyclo-
propanation for MAMEs isolated from the pcaA mutant
(Figures S1E and S1F). These results indicate both that
M. marinum PcaA performs the same function as in other my-
cobacteria and that the transposon insertion produces a
loss-of-function allele.
We then compared the in vivo angiogenic activity of wild-type
purified MAGs with those isolated from the pcaA mutant and
complemented mutant strains. Using the droplet administration
method developed earlier, we injected equivalent doses of the
purified MAGs from each strain into separate groups of larvae.
MAGs from wild-type and complemented mutant bacteria
consistently induced angiogenesis at a level equivalent to puri-518 Cell Host & Microbe 24, 514–525, October 10, 2018fied TDM, whereas this fraction from the
pcaAmutant failed to induce angiogenesis
above the vehicle control (Figures 2D–2H).
The purified TDM control, wild-typeMAGs,
and complemented mutant MAGs all also
exhibited an increase in the frequency
at which abnormal vascularization was
observed compared with either vehicle
alone or mutant MAGs (Figures 2E and
2G). Thus, loss of cis-cyclopropyl-modi-fied mycolic acids abrogates the ability of these lipids to induce
robust angiogenesis in vivo.
pcaA Mutants Fail to Induce Vegfa Expression
We have previously demonstrated that the Vegf receptor ligand
Vegfaa is induced around sites of infection with wild-type M.
marinum (Oehlers et al., 2015). VEGFA has been reported to be
expressed in human granuloma macrophages, where extensive
vascularization also occurs (Datta et al., 2015). Given the require-
ment and sufficiency of cyclopropanated TDM for granuloma-
associated angiogenesis, we hypothesized that the non-modi-
fied TDM present in pcaA mutants might fail to induce Vegfaa.
We utilized a transgenic line in which vegfaa regulatory se-
quences direct expression of an EGFP reporter transgene
(TgBAC(vegfaa:EGFP)pd260 (Karra et al., 2018). During larval
development the vegfaa reporter is driven in the developing
vasculature at low levels in a stereotyped pattern throughout
the animal (Karra et al., 2018). However, larvae infected with
wild-type bacteria exhibited robust activation of this reporter at
the granuloma (Figures 3A and 3B). In contrast, larvae infected
with pcaA mutant bacteria largely failed to induce any robust
signal above the developmental expression level, despite the
formation of well-structured granulomas (Figures 3A and 3B).
Larvae infected with the complemented mutant strain exhibited
an intermediate phenotype, with 3-fold greater reporter induc-
tion on average compared with themutant strain (Figures 3A and
3B). These data implicate PcaA-dependent chemical modifica-
tion of TDM in specifically promoting Vegfaa activation within
the granuloma and suggest that TDM-dependent angiogenesis
proceeds through engagement of the canonical pro-angiogenic
Vegf signaling pathway.
Previous characterization of the M. tuberculosis pcaA
knockout strain in the murine model revealed a reduced host
Figure 4. Inducible and Pharmacological
Blockade of Vegf Pathway Activation Abro-
gates TDM-Induced Angiogenesis
(A) Quantification of abnormal vasculature at 2 dpi
for larvae with and without the Tg(hsp70l:dn-vegfaa)
transgene. ***p < 0.001, Student’s t test.
(B) Comparison of the frequency of the presence or
absence of abnormal vasculature between larvae
with or without the Tg(hsp70l:dn-vegfaa) transgene
after blinded scoring. Data from three experiments
combined. **p < 0.01, Fisher’s exact test.
(C) Quantification of abnormal vascularization at
2 dpi for larvae treated with either the pan-Vegf re-
ceptor inhibitor Pazopanib (250 nm) or vehicle (0.1%
DMSO). ***p < 0.001, Student’s t test.
(D) Phenotype frequency for vehicle- and Pazopa-
nib-treated groups. Data from three experiments
combined. ***p < 0.001, Fisher’s exact test.tumor necrosis factor (TNF) response during early infection (Rao
et al., 2005). As the timing of Vegf induction occurs near the
timing of the murine host TNF deficit, we wondered whether a
reduced TNF response might play a role in the lack of angiogen-
esis in pcaAmutant infections. We first utilized the tnfa transcrip-
tional reporter transgenic line TgBAC(tnf:GFP)pd1028 (Marjoram
et al., 2015). We infected these larvae with wild-type, pcaA
mutant, or complemented mutant M. marinum, and assessed
the bacterial burden and GFP signal for each larva at 3 dpi. We
found that there were no differences on average in GFP signal
or relative TNF transcript levels among each group (Figures
S4A–S4D).
To test functionally whether TNF signaling plays a role in Vegf
pathway activation during infection, we generated mosaic
CRISPR/Cas9 knockouts of TNF receptors 1 and 2 in TgBAC
(vegfaa:EGFP) larvae.After infectionwithM.marinumweassessed
bacterial burdensandGFPsignal in the vegfaa reporter lineat 5dpi
for each group. In TNF receptor-edited animals, bacterial burden
was increased (Figure S4F), consistent with previous reports
(Clay et al., 2008), and suggesting that the edited animals were
indeed functionally deficient in TNF signaling. However, no differ-
ences were observed in vegfaa reporter signal between the two
groups (Figures S4E and S4G). Thus, the pcaA-dependent vegfaa
induction appears to be independent of TNF signaling.
Genetically Encoded, Inducible Blockade of Vegf
Signaling Abrogates TDM-Induced Angiogenesis
We next tested whether TDM-induced angiogenesis was
functionally dependent on Vegf signaling in vivo. We utilizedCell Host & Ma validated transgenic zebrafish line
in which a heat shock-inducible pro-
moter drives a dominant-negative form
of Vegfaa (Tg(hsp70l:dn-vegfaa)bns100),
enabling temporally controlled inhibition
of Vegf signaling (Marin-Juez et al.,
2016). This dominant-negative form of
Vegfaa functions by promoting the for-
mation of an inactive heterodimer of
native Vegfaa and dn-Vegfaa incapable
of inducing Vegfr2 dimerization and sub-sequent pro-angiogenic signaling (Muller et al., 1997; Rossi
et al., 2016).
To test a requirement for Vegf induction in TDM-induced
angiogenesis, Tg(hsp70l:dn-vegfaa);Tg(kdrl:EGFP) larvae were
heat shocked immediately prior to TDM injection at 2 dpf and
heat shocked again at 3 dpf, followed by imaging at 4 dpf. Larvae
were genotyped post hoc to distinguish dominant-negative veg-
faa-expressing larvae from wild-type siblings. Animals express-
ing dominant-negative vegfaa showed dramatically reduced
TDM-induced angiogenesis compared with heat-shocked wild-
type siblings (Figures 4A and 4B). Thus, targeted genetic inhibi-
tion of Vegf is sufficient to abrogate TDM-induced angiogenesis.
To further validate these findings, we utilized a known small-
molecule pan-Vegf receptor inhibitor, Pazopanib, which has
been previously shown to effectively inhibit Vegf-dependent
angiogenesis in humans and zebrafish (Oehlers et al., 2015;
Podar et al., 2006). We injected Tg(kdrl:EGFP) larvae with
TDM at 2 dpf, and randomly sorted half of the injected larvae
into either E3 media containing vehicle (0.1% DMSO final con-
centration) or 250 nM Pazopanib. Similar to the heat shock-
induced expression of dn-Vegfaa, treatment with Pazopanib
abrogated the ability of TDM to induce angiogenesis in vivo
(Figures 4C and 4D).
Wild-Type M.marinum Growth Advantage Begins with
the Onset of Angiogenesis
To examine the link between compromised angiogenesis and
reduced bacterial growth, we temporally assessed pcaAmutant
growth deficiency relative to wild-type infection. Larvae wereicrobe 24, 514–525, October 10, 2018 519
infected with equal initial burdens of either wild-type, pcaA mu-
tants, or the PcaA-complemented strain, and infection burdens
were assessed at 1, 3, 4, and 5 dpi. Angiogenesis typically coin-
cides with the beginning of granuloma formation at 3–4 dpi (data
not shown). We observed identical in vivo growth among all three
bacterial strains between days 1 and 3, suggesting that altered
TDM does not lead to early differences in the ability of macro-
phages to restrict infection (Figures 5A and 5C). Instead, the
pcaA mutant growth defect emerged only later, at 4 dpi, and
became more pronounced at 5 dpi relative to wild-type (Figures
5A and 5C).
In addition, we used qRT-PCR to assess relative M. marinum
16S rRNA content from total RNA isolated from each group of
larvae. The relative differences in burden among the three
groups using this method were nearly identical to relative differ-
ences measured via fluorescent area (Figure S5G). This pcaA-
dependent growth defect coincided with the observed
decreased vascularization in the pcaA mutant at 4 dpi (Fig-
ure 5B). The burden and angiogenesis differences could be
rescued by constitutive bacterial expression of PcaA (Figures
5A–5C). Taken together, these findings suggest that the loss of
pcaA-dependent angiogenesis at 4 dpi may underlie the growth
defect observed in pcaA mutant mycobacteria.
While these data suggested that reduced angiogenesis pre-
ceded reduced burden in pcaA mutants, we next probed more
definitively whether reduced angiogenesis underlies the burden
decreases in pcaA mutants. Taking advantage of the natural
variability in zebrafish larval infections, we had previously found
that wild-type M. marinum infection burden and infection-
induced vascularization are positively correlated (Oehlers et al.,
2015). We observed the same correlation of burden and vascu-
larization for infections with wild-type or complemented pcaA
mutant bacteria (Figures S5A and S5C), but no correlation be-
tween burden and angiogenesis for the pcaAmutant strain (Fig-
ure S5B). These results suggested that even high pcaA mutant
burdens do not trigger robust angiogenesis.
Similarly, we compared levels of angiogenesis within the
subset of data for which pcaA mutants and wild-type bacteria
could be burden matched. Even under these constraints, pcaA
mutant infections were severely compromised for angiogenesis
compared with both wild-type and complemented strains (Fig-
ures S5D–S5F). Together, these analyses support a cause-
and-effect relationship in which the pcaA mutant in vivo growth
defect is downstream of an inability to induce robust granuloma
vascularization.
Bacterial pcaA Mutant Deficits Are Non-cell
Autonomous
To further probe the relationship between vascularization and
burden, we reasoned that co-infection of differentially labeled
wild-type and pcaAmutants would enable us to distinguish bac-
terium cell-autonomous effects of themutation (for example, any
compromised fitness arising from alterations of bacterial cell wall
structure) from non-cell-autonomous effects relating to alter-
ations in overall host environment. We co-infected animals with
wild-typeM.marinum in one color and pcaAmutants in a second
color, and monitored the growth of each strain independently.
We found that wild-type M. marinum could rescue both the
pcaA angiogenesis and burden deficits in co-infected granu-520 Cell Host & Microbe 24, 514–525, October 10, 2018lomas (Figures 5D–5F), further corroborating a principal role for
non-cell-autonomous processes such as angiogenesis as the
basis for the pcaA phenotype.
PcaA Mutants Exhibit a Growth Defect as a Result of a
Failure to Engage the Vegf Pathway
Based on these data and in vivo imaging of the vegfaa
reporter, we hypothesized that the loss of vascularization and
restricted growth in the pcaA mutant resulted from a failure
of Vegf-dependent vascularization. We infected Tg(kdrl:EGFP)
and Tg(kdrl:EGFP);Tg(hsp70l:dn-vegfaa) larvae with wild-type
or pcaA mutant M. marinum, heat shocked once a day at
3 and 4 dpi, and analyzed bacterial burden and vasculature at
5 dpi. In animals infected with wild-type M. marinum, we found
that, as expected, there was a significant reduction in both
angiogenesis (Figure 6B) and bacterial burden for the induced
transgenic larvae (Figures 6A and 6C). Although small-molecule-
and antibody-based manipulation of this pathway has been re-
ported previously in mycobacterial infection (Datta et al., 2015;
Oehlers et al., 2015), these results provide direct genetic evi-
dence that inhibition of Vegf signaling is host-beneficial in early
mycobacterial infection.
In contrast, inducible inhibition of Vegfaa signaling in the pcaA
mutants had no effect on burden (Figure 6A). Thus, in vivo, the
entirety of physiologically relevant Vegf production during early
infection is pcaA dependent. Consistent with the requirement
for pcaA in Vegf induction, the infection burden in dn-Vegfaa
larvae infected with wild-type bacteria was reduced to the level
seen in the pcaA mutant infections. These data demonstrate
that Vegf pathway activation is a bacteria-beneficial host pro-
cess for pathogenicmycobacteria during early infection and pro-
vide additional evidence that the defects observed for the pcaA
mutant derive from its inability to activate the Vegf pathway and
vascularize infection foci.
DISCUSSION
Pathogenic mycobacteria are capable of both evading the host
immune response and reprogramming host phagocytes in order
to modify their environment. It is known that granulomas formed
duringM. tuberculosis infection initially become highly vascular-
ized, and this angiogenesis has been shown to facilitate bacterial
growth, likely by mitigating hypoxia and nutrient deprivation
within the granuloma interior and promoting dissemination (Aly
et al., 2007; Oehlers et al., 2015; Tsai et al., 2006; Ulrichs et al.,
2005). Previous work found that granuloma angiogenesis is
macrophage dependent, and host-directed chemical inhibition
of Vegf signaling abrogates vessel growth and reduces bacterial
fitness (Oehlers et al., 2015), implying that pathogenic mycobac-
teria may drive or enhance this process within the host.
Here, we leveraged the unique advantages of the zebrafish
model to demonstrate that specific chemical modifications to
mycolic acids, a unique class of lipids constituting the major
component of the outer cell wall of mycobacteria, are largely
responsible for the early vascularization of infection foci. Specif-
ically, we found that proximal cis-cyclopropanation of the
mycolic acid tails of TDM is the major angiogenic component
of mycolic acid-containing cell wall lipids. This modification
has previously been reported to play a role in interactions with
Figure 5. pcaA Mutant Bacteria Exhibit In vivo Growth Defects Coinciding with Onset of Granuloma Angiogenesis
(A) Five-day time course of larvae infectedwith wild-type, pcaAmutant, or complementedmutantM.marinum strains. Bacterial burdens weremeasured at 1, 3, 4,
and 5 dpi. At 4 dpi pcaAmutants exhibit a reduced growth rate, which persists through 5 dpi. The complementedmutant strain exhibits wild-type levels of growth
throughout. Representative of three independent experiments. *p < 0.05; one-way ANOVA with Dunnett’s multiple comparison post-test. n = 40 for each group.
(B) Quantification of abnormal vascularization. The timing of the growth defect correlates with the onset of robust vascularization for wild-type and complemented
strain infections but a failure to extensively vascularize infection foci for pcaA mutant strain infections. ****p < 0.0001; one-way ANOVA with Tukey’s multiple
comparison post-test. n = 40 for each group.
(C) Representative images of larvae at 5 dpi infected with each of theM.marinum strains. Wild-type, upper panel; pcaAmutant, middle; complemented mutant,
lower. Scale bars, 500 mm.
(D–F) Larvae possessing the Tg(kdrl:EGFP) transgene were co-infected with wild-type and PcaAmutantM.marinum. Bacterial burden (D) and length of abnormal
vasculature (E) were quantified for each larva at 5 dpi. *p < 0.05; **p < 0.01; ****p < 0.0001; one-way ANOVA with Tukey’s multiple comparison post-test. Data
shown represent an aggregate of two independent experiments. n = 27 for wild-type infections alone; n = 27 for pcaA mutant infections alone; n = 28 for co-
infection. (F) Representative images of each infection. Upper panels: merge of bright-field and fluorescent channels. Red depicts wild-type M. marinum; blue
depicts pcaAmutantM.marinum; purple depicts co-localization between the two strains. Dotted lines denote the area shown in lower panels. Scale bars, 500 mm.
Middle panels: fluorescent channels alone, showing infection burden. Lower panels: vasculature. Blue arrows denote intersegmental vessel growth characteristic
of granuloma angiogenesis. Scale bars, 100 mm.
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Figure 6. Vegf Pathway Blockade Inhibits
In Vivo Growth of Wild-Type but Not pcaA
Mutants
(A) Bacterial burden of larvae with or without the
Tg(hsp70l:dn-vegfaa) transgene at 5 dpi, infected
with either wild-type or pcaA mutant M. marinum.
Expression of the transgene induces a reduction in
wild-typeM.marinum burden compared with larvae
without the transgene. Expression of the transgene
had no effect on the bacterial burdens of larvae in-
fected with the PcaA mutant strain. *p < 0.05; **p <
0.01; one-way ANOVA with Tukey’s multiple com-
parison post-test. n = 31 and n = 55 for wild-type
infections in larvae without or with the Tg(hsp70l:dn-
vegfaa) transgene, respectively; n = 33 and n = 39
for pcaA mutant infections in larvae without or with
the Tg(hsp70l:dn-vegfaa) transgene, respectively.
(B) Quantification of abnormal vasculature during
wild-type infections for Tg(kdrl:EGFP)+ larvae with
or without the Tg(hsp70l:dn-vegfaa) transgene. The
double transgenic larvae were present as a subset
of the cross between the Tg(kdrl:EGFP) and
Tg(hsp70l:dn-vegfaa) transgenic lines. Induction of
the Tg(hsp70l:dn-vegfaa) transgene results in a
reduction in infection-induced angiogenesis. *p <
0.05, Student’s t test. n = 16 and n = 25 for larvae
without or with the Tg(hsp70l:dn-vegfaa) transgene,
respectively.
(C) Representative images of vascularization in
larvae with the Tg(hsp70l:dn-vegfaa) transgene
(right panels) and without (left panels). Upper
panels: bright field, with the dotted line depicting
regions shown in the lower panels. Scale bars,
500 mm. Middle panels: merge of vasculature and
infection. Lower panels: vasculature alone. Scale
bars, 100 mm. All quantitation performed blind to
genotype.innate immune cells, but its role in angiogenesis had not been
examined (Glickman et al., 2000; Rao et al., 2005).
Loss of these cis-cyclopropanated lipids during infection
leads to a reduced overall bacterial burden that coincides
with the normal onset of granuloma vascularization. The in vivo
pathogen growth deficiency during this period appears to be
largely if not entirely driven by a defect in Vegf pathway activa-
tion after granuloma formation. VEGFA induction in granuloma
macrophages has consistently been reported to be a feature of
mycobacterial infection in non-human primates and in humans
(Datta et al., 2015; Matsuyama et al., 2000; Polena et al., 2016).
Similarly, in zebrafish, Vegfaa production arises in granuloma
macrophages, and angiogenesis is macrophage dependent
(Oehlers et al., 2015). Here, using transgenic lines, we found
that Vegfaa production arises at the granuloma in a pcaA-
dependent fashion, and that selective genetic inhibition of Veg-
faa signaling alone reduces bacterial burden to pcaA mutant
levels.
These data suggest that vascularization of mycobacterial
granulomas is not merely a passive phenomenon driven by the
host response to dense, hypoxic cell aggregates. Rather, path-
ogenic mycobacteria actively promote or accelerate angiogen-
esis, expending energy by chemically modifying a cell wall lipid
in amanner that, while not essential for viability, nonetheless cre-
ates a significant growth advantage in vivo.522 Cell Host & Microbe 24, 514–525, October 10, 2018TDM engages multiple host pathways that may promote
mycobacterial pathogenesis, and thus the molecule may induce
pleiotropic effects (Axelrod et al., 2008; Hunter et al., 2006;
Indrigo et al., 2003; Middlebrook et al., 1947; Patin et al., 2017;
Sakamoto et al., 2013). Here, however, we find that one specific
chemical modification drives TDM’s angiogenic activity via Veg-
faa induction. Importantly, the pcaA mutants were not defective
for initial in vivo growth within macrophages over the first 3 days
of infection, and burden defects coincided with differences in
angiogenesis. No additional burden defects emerged in the
pcaA mutants upon genetic blockade of Vegfaa signaling, sug-
gesting that the physiologically relevant effects of Vegfaa during
early mycobacterial infection may be entirely pcaA dependent.
In cell culture models and in mice, M. tuberculosis pcaA mu-
tants were shown to induce less initial TNF and to have a growth
deficit at 7 dpi, although there was recovery to wild-type bacte-
rial numbers at later time points (Rao et al., 2005). However, the
effects we have observed on angiogenesis are difficult to trans-
late or probe in standard mouse models; C57Bl/6 mouse M.
tuberculosis granulomas do not form the extensively structured
hypoxic granulomas observed in human disease (Harper et al.,
2012; Tsai et al., 2006).
The Vegf dependence of the wild-type growth advantage we
observed in this study may be complementary to the previously
observed TNF-dependent growth advantage (Rao et al., 2005).
Pathogenic angiogenesis possesses a complex relationship with
TNF. Short TNF pulses early in inflammation can prime endothe-
lial cells for sprouting and proliferation while simultaneously
blocking Vegf signaling, delaying but ultimately promoting angio-
genesis (Sainson et al., 2008). In our model, however, TNF
signaling does not appear to be crucial for early Vegf induction.
Other reported activities of TDMmay also influence vasculariza-
tion at the mycobacterial granuloma; TDM can induce macro-
phage expression of MMP9, which has been implicated in
angiogenesis via mobilization of VEGF as well as granuloma for-
mation (Bergers et al., 2000; Sakamoto et al., 2013; Volkman
et al., 2010).
Triggering host angiogenesis at the outset of infection may
provide a mechanism by which mycobacteria maximize growth
prior to subsequent restriction by host immunity. By initiating
angiogenesis, the pathogen not only increases the delivery of ox-
ygen and nutrients, but also generates conduits through which it
may spread to distal tissue sites to establish a multi-focal infec-
tion (Oehlers et al., 2015; Polena et al., 2016). We have shown
here and previously that interception of the Vegf and other pro-
angiogenic pathways can be used to limit mycobacterial growth
during infection, including in adult, established infections (Oeh-
lers et al., 2015, 2017). Thus, host components engaged by
cis-cyclopropanated TDM upstream of Vegfaa induction are
attractive targets for further study. A fuller understanding of
host interactions with this specific mycobacterial lipid may yield
druggable targets in the host that have the potential to synergize
with current anti-tubercular therapies via modulation of granu-
loma vasculature.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Zebrafish (Danio Rerio)
All zebrafish husbandry and experimental procedures were performed in accordance and compliance with policies approved by the
Duke University Institutional Animal Care and Use Committee (protocol A122-17-05). Unless otherwise indicated, all zebrafish are
derived from the wildtype AB strain.
Adult Zebrafish Housing
Adult zebrafish used to generate all the larvae used in this study were housed together by transgenic genotype in 3 or 10 L tanks.
Water conditions are as follows: temperature: 28C; conductivity: 600-700 mS (maintained with Instant Ocean Sea Salt);
pH: 7.0-7.3 (maintained with sodium bicarbonate; Arm & Hammer Pure Baking Soda).
Larval Zebrafish
All larval zebrafish used in this study were euthanized on or before 8 dpf. At these ages, sex is indeterminate for zebrafish (Liew and
Orban, 2014; Uchida et al., 2002), and so no distinctions between male and female are made in the studies presented here.
Larvae weremaintained at a temperature of 28.5C in 100mm petri dishes in 40-50ml of sterile E3media (5 mMNaCl, 178 mMKCl,
328 mM CaCl2, 400 mM MgCl2) at a maximum density of 50 larvae per dish. In all cases, at 1 dpi larvae were transferred to E3 sup-
plemented with 1-phenyl-2-thiourea (PTU, Sigma-Aldrich cat# P7629), final concentration 45 mg/ml) to arrest pigment development.
In all cases, anesthesia was performed with the addition of Tricaine (Sigma Aldrich, cat# E10521) to a final concentration of
160 mg/ml. Unless otherwise stated, larvae were anesthetized prior to any manipulation (i.e., moving between dishes, microinjection,
live imaging, etc.). Time in anesthetic was limited to the minimum amount of time required to perform the desired manipulation.
Mycobacterium Marinum
Wildtype
All strains used are derived from the M. marinum M strain. The wildtype M. marinum strain, expressing the tdTomato fluorescent
protein and Hygromycin B resistance genes, has been described previously (Oehlers et al., 2015). Culture of wildtype bacteria
was carried out on either 7H10 agar supplemented with Middlebrook OADC growth supplement (10% v/v; Sigma-Aldrich cat#
M0678) and 50 mg/ml Hygromycin B or liquid 7H9 media supplemented with Middlebrook OADC growth supplement (10% v/v),
0.05% Tween 80 (Sigma-Aldrich cat# P1754), and 50 mg/ml Hygromycin B. Liquid 7H9 media containing OADC and Tween 80 is
referred to hereafter as 7H9 Complete.
Transposon Mutants
The two transposonmutants with disruptions in the pcaAORF (pcaATn20324 and pcaATn28776) were identified from a sequenced library
ofM.marinum transposon mutants (C. Cosma and L. Ramakrishnan), and the previously identified insertion sites were confirmed by
PCR and sequencing. Primers used were F primer (annealing upstream of the 5’ end of the pcaA ORF): 5’-AAGCCCTGTGGAACA
GAAAG-3’; R primer (annealing downstream of the 3’ end of the pcaA ORF): 5’-ATCAAGCCAACACGCCTG-3’; and TnMarR3
(annealing within the transposon and directing amplification across the 3’ junction with genomic DNA): 5’-ACAACAAAGCTCTCAC
CAACCGTG-3’. The following primer pairs were used in separate reactions for each of the mutants as well as a no template control:
F/TnMarR3; R/TnMarR3. Of the PCRs performed, amplicons were generated only from F/TnMarR3 using pcaATn28776 template and
R/TnMarR3 using pcaATn20324 template. Sequencing of the amplicons using TnMarR3 confirmed disruptive insertions of the trans-
posons into the pcaA ORFs of both strains.
Transposon mutants possessed the TnMar transposon, conferring resistance to Hygromycin B. Fluorescent transposon mutant
strains were generated via electroporation (800 U, 25 mF, 2.5 kV, 0.2 cm gap) with plasmid msp12:mCerulean-KanR (a gift from
L. Ramakrishnan, University of Cambridge), resulting in the expression of the mCerulean fluorescent protein and conferring resis-
tance to Kanamycin. Culture of transposon mutant strains was carried out using the same media as with wildtype bacteria except
for the addition of 20 mg/ml Kanamycin to the media.
Complementation of the pcaATn28776 Strain
The pcaA open reading frame (ORF) was amplified from wildtype M. marinum genomic DNA (F primer: 5’-AATCACTTCG
CAATGTCCGTCCAGCTCACG-3’; R primer: 5’-GTCGATCGTACGCTACTTCTCCAAAGTGAACTGA-3’). The pMV261-KanR plasmid
(a gift from the Ramakrishnan lab) that contained theM. tuberculosis groEL promoter (referred to hereafter as hsp60) was amplified
and linearized via inverse PCR (F primer: 5’-TAGCGTACGATCGACTGC-3’; R primer 5’-CATTGCGAAGTGATTCCTCC-3’). The two
fragments were ligated together via InFusion (Clontech) producing a plasmid conferring resistance to Kanamycin with the pcaAORF
immediately downstream of the mycobacterial hsp60 promoter (referred to hereafter as pMV261-PcaA-KanR).
A fragment containing the hsp60 promoter and pcaA ORF was amplified from pMV261-PcaA-KanR (F primer: 5’- TCTCAT
CAACCGTGGAAATCTAGAGGTGACCACAACG-3’; R primer: 5’-TCCAGCCAGAAAGTGTTGTTGGCTAGCTGATCACC-3’). The
entire msp12:mCerulean-KanR plasmid was amplified and linearized via inverse PCR (F primer: 5’- CACTTTCTGGCTGGAT
GATG-3’; R primer: 5’-CCACGGTTGATGAGAGCT-3’). The two fragments were ligated together via Infusion (Clontech) producing
a plasmid conferring Kanamycin resistance as well as mycobacteria-specific constitutive expression of both the mCerulean fluores-
cent protein (msp12 promoter) and M. marinum PcaA (hsp60 promoter), referred to hereafter as pMCHP-KanR.
pMCHP-KanR was electroporated into pcaATn28776, resulting in a Kanamycin/Hygromycin B-resistant mutant strain overex-
pressing PcaA and mCerulean.Cell Host & Microbe 24, 514–525.e1–e6, October 10, 2018 e2
METHOD DETAILS
Microinjection of M. marinum
All strains were prepared for infection in the same manner, as described previously (Takaki et al., 2013). Bacteria were cultured at
33C in 50ml 7H9 complete with the appropriate antibiotic(s) without shaking. At OD600 of 0.5-0.6, cultures were collected by centri-
fugation at 4000 x g for 20 min. Cultures were washed 3x with dH2O to remove all traces of antibiotic, and resuspended in 1 ml of
Freezing 7H9 (7H9 supplemented with 10% v/v Middlebrook OADC). The concentrated suspension was centrifuged at 770 x g,
and the unpelleted bacteria in the supernatant were transferred to a fresh tube. The pellet was then resuspended in 1 ml Freezing
7H9 using a syringe. Centrifugation, supernatant collection, and resuspension were repeated until all bacteria had been transferred
to the new collection tube. The entire volume of collected supernatants was then filtered through a 5 mm nylon syringe filter, and
centrifuged at 14,000 x g for 5 min. The pellet was resuspended in 0.5 ml of Freezing 7H9, and bacteria concentration was elucidated
by averaging the count of fluorescent bacteria of several serial dilutions. The concentrate was adjusted to 5.0 x 108 bacteria/ml with
Freezing 7H9, distributed into 5 ml aliquots, and stored at 80C.
Infections with either wildtype, transposon mutant, or complemented mutant M.marinum were performed as described (Oehlers
et al., 2015). Briefly, larvae at 2 dpf were anesthetized with Tricaine and injected with 100-200 fluorescent bacteria dorsally near the
rostral/caudal midline.
Microinjection of TDM, MAMEs, and MAGs
TDM (Sigma Aldrich, cat# T3034, purified fromM. bovis; or BEI Resources cat# NR-14844, purified from M. tuberculosis H37Rv) at
2 mg/ml in Incomplete Freund’s Adjuvant (Sigma Aldrich, cat# F5506) was dissolved in 2:1 chloroform:methanol to generate stock
solutions of 1 mg/ml and 250 mg/ml, respectively. MAMEs (BEI Resources cat# NR-14854, purified fromM. tuberculosis H37Rv) was
dissolved in 2:1 chloroform:methanol to generate a stock solution of 1mg/ml. MAGs purified from the various M. marinum strains
used in this study were dissolved TDM and MAMEs were prepared for injection by evaporating a small volume of the stock solution
under gentle airflow, and resuspending in and appropriate volume of IFA to achieve 2mg/ml final concentration. Larvae at 2 dpf were
anesthetized in Tricaine in E3media and injected with approximately 10-20 nl of TDM/IFA or MAMEs/IFA (See Figure 1 for anatomical
location). Control larvae were injected with the same volume of IFA alone. Larvae were then washed once in E3 and transferred to
fresh E3 supplemented with PTU to continue arresting pigment development.
Purification of MAGs from M. marinum
Wildtype and pcaATn28776 M. marinum were first inoculated from freezer stocks into 3 ml of 7H9 Complete liquid media starter cul-
ture supplemented with 50 mg/ml Hygromycin B, and incubated at 33C in static culture until late log phase (OD600 of 0.8-1). The
pcaATn28776::pcaA strain was grown under identical conditions except for the addition of 20 mg/ml Kanamycin. Cultures were spun
down and resuspended in 1 ml fresh 7H9 Complete media, and added to 500 ml of 7H9 Complete with appropriate antibiotic(s).
Cultures were grown at 33C with gentle shaking until mid-log phase (OD600 of 0.5-0.7). Purification of mycolic acid-containing
glycolipids was then performed separately for each culture, as described (Parish and Stoker, 2001). Briefly, bacteria were collected
and washed 3x with dH2O, resuspended in 10 ml 2:1 chloroform:methanol, and incubated at room temperature overnight in a
sealed container with vigorous stirring. The crude extract was collected, spun down to pellet insoluble debris, and slowly added
to 500 ml acetone at -20C and incubated overnight. Precipitate was recovered by spinning at 20,000x g for 15 min at 4C, dis-
carding the supernatant and resuspending in 2 ml 2:1 choloform:methanol. The solvent was evaporated under gentle airflow, and
recovered material was weighed on an analytical balance. Each preparation was then resuspended at 5 mg/ml in 2:1
chloroform:methanol.
Purification of MAMEs from M. marinum
M. marinum strains were cultured as previously described for the MAG isolations. Alpha MAMEs were isolated by preparative TLC
using EMD Millipore TLC Silica Gel 60 (Thermo Fisher Scientific cat# M1057150001) from crude MAMEs extracts. Briefly, 10 mg of




TLC was performed on EMD Millipore TLC Silica Gel 60 (Thermo Fisher Scientific cat# M1057150001) as described (Pirson et al.,
2012), with impregnation with 10% silver nitrate in water as described (Kennerly, 1986). Briefly, impregnation was carried out by sub-
merging the TLC plate in the silver nitrate solution for 30 seconds. The plate was then allowed to dry at room temperature for 1 hour
followed by baking at 50C, 80C, and 100C in a stepwise fashion for 20min at the first two temperatures and 40 min at the last.
Plates were then allowed to cool at room temperature for 20 min before use. 20 mg of lipid extract in methylene chloride was spotted
on the plate and allowed to dry prior to running in a 100:14:0.8 chloroform:methanol:water solution. The plate was developed by sub-
mersion in a 10% sulfuric acid in methanol followed by charring. Plates were imaged using a Google Pixel camera.
MAMEs
TLC of the MAMEs isolates was performed in the same manner as for the MAG isolates, with the following exceptions. The isolates
were developed 2x in 95:5 hexanes:ethyl acetate. 1H NMR was performed at 500 MHz with the sample dissolved in CDCl3.e3 Cell Host & Microbe 24, 514–525.e1–e6, October 10, 2018
Generating TNFR1/TNFR2 Mosaic Knockout Larvae
sgRNA Synthesis
Target sites within the tnfrsfa and tnfrsfb loci were identified using the sgRNA prediction tool at www.crisprscan.org (Moreno-Mateos
et al., 2015). Single stranded DNA oligos used to generate the sgRNA transcription templates for the tnfrsfa and tnfrsfb targets were
5’-taatacgactcactataGGGCTGGACGAGGTCCCTATgttttagagctagaa-3’ and 5’-taatacgactcactataGGTGCAATGCAGTACTGCTTgt
tttagagctagaa-3’, respectively.
Double-stranded template assembly was performed via PCR using Q5 DNA Polymerase (NEB) with either of the above oligos and
the constant tail oligo 5’-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTC
TAGCTCTAAAAC-3’. Cycling parameters: 98C, 1 min; 14 cycles of 98C, 10s, 45C, 30s; 72C, 15s. 1mg of template was used in
an in vitro transcription reaction using the MEGAShortscript T7 Transcription Kit per the manufacturer’s instructions (Thermo Fisher
Scientific cat# AM1354). sgRNAs were purified using RNeasy Mini Kit (Qiagen cat# 74104).
Injection into Single Cell Embryos
Single cell embryos of the TgBAC(vegfaa:EGFP) were injected with 10nl of the following mixture: 800ng/ul Cas9 protein (IDT,
cat#1074182), 300mM KCl, 265ng/ml sgRNA.
Assessment of Lesions at Target Loci
Genomic DNA was extracted from whole larvae at 5 dpi at the conclusion of the experiment in the same manner as described
previously. 1ul of a 1/10 dilution of this extract was used as a template for HRMA using the MeltDoctor HRM Master Mix (Thermo
Fisher Scientific) per the manufacturer’s instructions. Primers for TNFR1: Forward – 5’-CTGCTATTTGCAGTTCACGAG-3’; Reverse –
5’-GGTCAATGTTCTGCTCAGAAAC-3’. Primers for TNFR2: Forward – 5’-CTCTTCTAGGGACTCGCTTG-3’; Reverse – 5’-GGA
CACTTGAAACAATTGGGA-3’. PCR andmelt profile were performed using the 7500 Fast Real-Time PCRSystem (Thermo Fisher Sci-
entific). Genotyping analysis was performed by HRM Software 3.0 (Thermo Fisher Scientific) (Figures S6A and S6B).
Generating FcRg Mosaic Knockout Larvae
sgRNA Synthesis
Target sites within the fcer1g and fcer1gl loci were identified using crisprscan.org.
Single stranded DNA oligos used to generate the sgRNA transcription templates for the fcer1g and fcer1gl targets were 5’-taatac
gactcactataGGCAGATGCGATGAGTCTGAgttttagagctagaa-3’ and 5’-taatacgactcactataGGCGGGATCCTGATCGTTTAgttttagagc
tagaa-3’, respectively. Templates were assembled in the same manner as for the TNFR sgRNA templates.
Injection into Single Cell Embryos
Tg(kdrl:EGFP) single cell embryos were injected with 10nl of the following mixture: 800ng/ul Cas9 protein (IDT, cat#1074182),
300mM KCl, 265ng/ml sgRNA.
Assessment of Lesions at Target Loci
Genomic DNA was extracted from whole larvae at 2 dpi at the conclusion of the experiments in the manner previously described.
HRMA was performed using the following primers: Primers for fcer1g: Forward – 5’- AACTTGTTGCTCAGTATGTTC-3’; Reverse –
5’-GACAGTGAGAACAATCCCATAG-3’. Primers for fcer1gl: Forward – 5’-GTTTCTCAGCTGCGCAACA-3’; Reverse – 5’-GATGCT
CACCTTTAATCTGCAG-3’. PCR and melt profile were performed using the 7500 Fast Real-Time PCR System (Thermo Fisher
Scientific). Genotyping analysis was performed by HRM Software 3.0 (Thermo Fisher Scientific) (Figures S6C and S6D).
Generating the myd88 Knockout Line
sgRNA Synthesis
Target sites within the myd88 locus were identified using crisprscan.org.
Single stranded DNA oligos used to generate the sgRNA transcription templates for the myd88 target was 5’-taatacgactcacta
taGGCGGCAGACTGGAGGACAGgttttagagctagaa-3’.
Templates were assembled in the same manner as described previously.
Injection into Single Cell Embryos
Tg(kdrl:EGFP) single cell embryos were injected with 10nl of the following mixture: 800ng/ul Cas9 protein (IDT, cat#1074182),
300mM KCl, 265ng/ml sgRNA.
Identification of Frameshift Alleles
Adult zebrafish derived from the injected embryos were crossed to wildtype fish, and the progeny were assessed via HRMA as
described previously. F primer: 5’-CCGAAAGAAACTGGGTCTGTTCC-3’; R primer: 5’- ACGAGTTTCCCAGTCCGTCA-3’. Larvae
exhibiting lesions at themyd88 target locus were further analyzed by sequencing, and an allele exhibiting a 22 base-pair deletion
was identified. This deletion begins at amino acid 39 (of 284) and results in a frameshift and premature translation termination
after 59 amino acids. F1 adult fish heterozygous for this allele were identified and pooled, and larvae used for the experiments
requiring myd88 knockouts were generated by crossing these F1 adults. The resulting progeny exhibited Mendelian ratios of
homozygous wildtype, heterozygous mutant, and homozygous mutant alleles via HRMA (See group N values, Figures S3C;
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Use of Tg(hsp70l:dn-vegfaa) Larvae
Heat Shock Conditions
For experiments involving TDM: All larvae subjected to heat shock were incubated at 37C for 75 min, occurring at -4 hrs and +20 hrs
with respect to the time of TDM injection. For experiments involving infection: Heat shocks occurred at 3 and 4 dpi; 37C for 75 min
each time.
Genotyping
Genomic DNA was extracted individually from whole larvae as described previously. Extracts were diluted 1:10 and 1 ml from each
larva was used as a template for PCR. Genotyping was carried out for up to 96 larvae in parallel using an Applied Biosystems 7500
Fast Real-Time PCR machine followed by High-Resolution Melt Analysis (HRMA) using MeltDoctor HRM Reagents (Thermo Fisher
Scientific). A competitive pair of PCRs were performed concurrently, allowing expedited, automated identification of transgene-con-
taining samples bymelt curve analysis. Briefly, one forward primer (Primer F1; 5’-GAGAACGGTGTGACGGTAAC-3’) anneals to the 3’
end of Intron 2-3 in the endogenous vegfaa locus; another forward primer (Primer F2; 5’-CTGCCCACATACCCAAAGAAG-3’) anneals
to the 5’ end of vegfaa Exon 2 in the endogenous locus and within the dn-vegfaa transgene; and a shared reverse primer (Primer R;
5’-GATGATGTCTACCAGCAGCTC-3’) anneals within Exon 3 of both the endogenous locus and within the dn-vegfaa transgene. The
resulting reaction generates different, highly reproducible amplicon pools depending on the presence/absence of the transgene,
which can be distinguished by HRMA (Figure S6F). HRMA patterns were initially assigned to genotypes based on analysis of a subset
of samples using a simple presence/absence PCR for the transgene followed by Agarose Gel Electrophoresis (F primer: 5’-CATGTG
GACTGCCTATGTTCATC-3’; R primer: 5’-CTTCTTTGGGTATGTGGGCAG-3’).
In vitro Growth Analysis
Starter cultures were generated by inoculating 1 ml 7H9 Complete with a stab of 80C freezer stock of each strain tested. Starter
cultures were allowed to grow to stationary phase. Bacteria were pelleted by centrifugation, and resuspended in 1 ml fresh 7H9
Complete. Each strain was then diluted in triplicate to a starting OD600 of 0.033 in 1 ml 7H9 Complete. Culture were incubated
at 33C with vigorous shaking. OD600 readings were taken each day at 24 hour intervals for 72 hours, and the readings from
each of three replicates was averaged for each timepoint per strain. Doubling times were calculated using GraphPad Prism 7. Briefly,
a best-fit non-linear regression using an exponential growth model was applied to each data series, fixing y=0.033 for t=0.
RT-qPCR
RNA extractions were performed using the TRIzol Reagent (Thermo Fisher Scientific cat# 15596026) per manufacturer’s instructions.
cDNA was generated for each group to be tested using the iScript cDNA Synthesis Kit (BioRad cat# 1708890) with an input of 1 mg
of RNA.
M.marinum 16S Burden Analysis
M.marinum-specific 16S primers were designed based on 16S hypervariable regions identified as best able to distinguish between
different Mycobacteria spp. (Chakravorty et al., 2007). F primer: 5’-CGATCTGCCCTGCACTTC-3’; R primer: 5’- CCACAGGACAT
GAATCCCGT-3’. RT-qPCR was performed using the Power SYBR Green PCR Master Mix (Thermo Fisher Scientific cat#
4367659) per the manufacturer’s instructions. b-actin transcript levels (zebrafish gene actb1) were used as the internal input control.
F primer: 5’-CGAGCAGGAGATGGGAACC-3’; R primer: 5’-CAACGGAAACGCTCATTGC-3’.
Zebrafish tnfa Induction Analysis. Zebrafish tnfa cDNA was amplified using F primer:
5’-CAGGGCAATCAACAAGATGG-3’; R primer: 5’-TGGTCCTGGTCATCTCTCCA-3’. RT-qPCR was performed as described for
M. marinum 16S cDNA. b-actin transcript levels were used as the internal input control.
Pazopanib Treatment
Pazopanib (Sigma-Aldrich cat# CDS023580) was used as described (Oehlers et al., 2015). Briefly, larvae were randomly assigned to
two 100 mm petri dishes containing 40 ml of E3 media immediately following injection with TDM. To one dish, 40 ml of DMSO was
added to achieve a final concentration of 0.1% v/v DMSO in E3 (vehicle group). To the other dish, 40 ul of a 250 mM stock of Pazo-
panib in DMSO was added to achieve a final concentration of 250 nM Pazopanib, 0.1% v/v DMSO in E3 (treatment group). Animals
were kept under these conditions continually for the duration of the experiment.
QUANTIFICATION AND STATISTICAL ANALYSIS
Image Analysis
Image analysis was performed using ImageJ (NIH). Abnormal angiogenesis wasmeasured by tracing the path of vasculature present
between intersegmental vessels. Bacterial burden for each larva wasmeasured by flattening image stacks in the relevant fluorescent
channel using amaximum intensity projection, setting a threshold for signal above background, andmeasuring total fluorescent area.
Background thresholds were held constant across all larva for a given time point and fluorescent channel.
TNF reporter induction in the transgenic line TgBAC(tnf:GFP)wasmeasured for each larva by flattening image stacks in the relevant
fluorescent channel using amaximum intensity projection, setting a threshold for signal above background, andmeasuring total fluo-
rescent area. Background thresholds were held constant across all larva for a given time point and fluorescent channel.e5 Cell Host & Microbe 24, 514–525.e1–e6, October 10, 2018
The transgenic line TgBAC(vegfaa:EGFP) possesses a high baseline signal due to normal activation of vegfaa during development.
Larvae were collected from a cross of adults heterozygous for the transgene in order to generate the largest possible pool of trans-
gene-positive larvae possible from the pool of adults on hand, and as a result the background signal varied by as much as two-fold
from larva to larva (i.e., one or two copies of the transgene). Because of this, vegfaa induction was measured in a slightly modified
manner: image stacks were first flattened using a maximum intensity projection. Background for a given larva was then measured by
recording the maximum value of fluorescent signal within an area of three uninfected somites. The resulting value was used to set the
threshold for that larva, and area of signal above the threshold was measured for the infected region. This process was repeated for
each individual larva.
Statistics
All statistics were performed using GraphPad Prism 7, and are noted for each analysis in the respective figure legends. Unless
otherwise noted in the figure legends, all comparisons are as follows: comparison of the average of two groups only utilized Student’s
t-test; comparison ofmore than two groups utilizedOne-way ANOVAwith Tukey’smultiple comparison post-test. Comparison of any
pair of contingency table datasets (absence vs. presence of phenotype) utilized Fisher’s exact test. For clarity, contingency table data
are displayed as percentage of total, with N=total number of animals listed above each bar. However, the statistical analyses were
performed on the untransformed values. In all cases, minimum significance for rejecting the null hypothesis for a given comparison is
p<0.05, denoted by *. ** denotes p<0.01; *** denotes p<0.001; and **** denotes p< 0.0001.Cell Host & Microbe 24, 514–525.e1–e6, October 10, 2018 e6
